LASIK increases night-time halos

Article

Patients undergoing LASIK procedures experience an increase in halos around lights in night vision conditions, according to a study published in the April issue of the British Journal of Ophthalmology.

Patients undergoing LASIK procedures experience an increase in halos around lights in night vision conditions, according to a study published in the April issue of the British Journal of Ophthalmology.

Cesar Villa Collar from the Clinica Oftalmologica Novovision, Spain and colleagues conducted a prospective, observational, analytical study to evaluate the changes in correlations of higher order aberrations (HOAs) of the first corneal surface with halo phenomena under night vision conditions. A total of 11 eyes that had undergone successful LASIK for myopia and astigmatism were examined. Preoperative sphere was -3.48±1.70 D and preoperative cylinder was -0.86±0.87 D. Visual disturbances and pupil size were measured after adaptation to a dark environment.

The halo disturbance index increased by a factor of 2.15 after successful LASIK surgery and total RMS for monochromatic HOA displayed a significant correlation with the halo disturbance index (r=0.36; p<0.01). However, only secondary astigmatism (r=0.36; p<0.01), coma (r=0.25; p=0.02) and spherical aberration (r=0.40; p<0.01) were responsible for this behaviour, with the remaining corneal aberrations until the 6th order not displaying any significant correlation.

It was concluded that LASIK can cause an increase in halos even when the results of the surgery are considered entirely satisfactory according to current international standards of predictability, efficacy and safety.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.